INIS
antibodies
36%
birth
36%
blood cells
36%
cardiolipin
36%
cardiovascular diseases
28%
comparative evaluations
19%
coronaviruses
36%
diseases
73%
distribution
36%
homeostasis
36%
infants
36%
inhibition
36%
kidneys
36%
liposomes
36%
liver
21%
losses
36%
lymphocytes
36%
matrices
76%
molecules
36%
muscles
73%
neutrophils
36%
patients
76%
plasma
36%
prophylaxis
36%
proteins
100%
risks
80%
thickness
30%
vitamin k
73%
walls
36%
width
36%
Keyphrases
At Birth
36%
Breast Milk
36%
Cardiovascular Disease
29%
Cardiovascular Markers
36%
Central Diastolic Blood Pressure
14%
Chronic Kidney Disease
36%
Chronic Kidney Disease Patients
14%
COVID-19
26%
Dephosphorylated Uncarboxylated Matrix Gla Protein
29%
Dp-ucMGP
21%
Elastic Fibers
15%
Extracellular Vesicles
36%
High Risk
36%
Hit Molecules
14%
Matrix Gla Protein
26%
Modifiable Risk Factors
36%
Neutral Sphingomyelinase
36%
Neutrophil-to-lymphocyte Ratio
36%
NSMase2
36%
PIVKA-II
31%
Preterm Infants
36%
Red Cell Distribution Width
36%
Severe Coronavirus Disease 2019
36%
Small Molecule Inhibitors
36%
Vascular Calcification
51%
Vascular Smooth muscle Cells
36%
Vitamin K
36%
Vitamin K Deficiency
36%
Vitamin K Status
36%
Vitamin K1
21%
Medicine and Dentistry
Acid Sphingomyelinase
36%
Aneurysm
18%
Aortic Dissection
18%
Blood Vessel Calcification
51%
C Reactive Protein
14%
Cardiovascular Disease
29%
Cardiovascular System
36%
Chronic Kidney Disease
36%
COVID-19
36%
Des-Gamma Carboxyprothrombin
49%
Desmosine
12%
Diastolic Blood Pressure
14%
Elastic Fiber
18%
Haptocorrin
29%
Homeostasis
36%
In Vitro
14%
Intima-Media Thickness
15%
Lymphocyte
36%
Matrix Gla Protein
54%
Neutrophil
36%
Osteocalcin
18%
Phylloquinone
36%
Procoagulant
12%
Protein S
12%
Prothrombin
21%
Red Blood Cell Distribution Width
36%
Thoracic Aortic Aneurysm
36%
Thromboembolism
12%
Vascular Smooth Muscle Cell
52%
Vitamin K Deficiency
36%